CYBERJAYA, Malaysia, Oct 1 (Bernama-PRNewswire) — The Malaysia Automotive, Robotics and IoT Institute (MARii) and Sengenics Sdn. Bhd. launched the ImmuSAFE COVID+ biochip, at MARii’s headquarters, Cyberjaya.
ImmuSAFE is the world’s first lab-based, multi-antigen, and multi-domain COVID-19 serology test (examination of blood serum) comprising of 9 functionally validated domains of the N and S protein of SARS-CoV-2 expressed using Sengenics’ KREX protein folding technology.